LEADER 01496nam a2200301 i 4500 001 991000933199707536 008 101105s2010 it b 001 0 ita d 020 $a9788864580203 035 $ab13934302-39ule_inst 040 $aDip.to Filologia Class. e Scienze Filosofiche$bita 082 $a174 100 1 $aVergari, Ughetta$0473884 245 10$aGovernare la vita tra biopotere e biopolitica /$cUghetta Vergari 260 $aTrento :$bTangram edizioni scientifiche,$c2010 300 $a181 p. ;$c23 cm 440 0$aIsegorìa : collana di scienze politiche, giuridiche e dell'amministrazione ;$v3 504 $aBibliografia: p. 165-174. Indice 650 4$aBioetica 907 $a.b13934302$b02-04-14$c05-11-10 912 $a991000933199707536 945 $aLE007 174 VER 01.02$g1$i2007000203262$lle007$op$pE15.00$q-$rl$s- $t0$u16$v25$w16$x0$y.i15193159$z05-11-10 945 $aLE007 174 VER 01.02$g2$i2007000203279$lle007$op$pE15.00$q-$rl$s- $t0$u7$v0$w7$x0$y.i15193184$z05-11-10 945 $aLE007 174 VER 01.02 $g3$i2007000203286$lle007$op$pE15.00$q-$rl$s- $t0$u6$v0$w6$x0$y.i15193196$z05-11-10 945 $aLE007 174 VER 01.02$g4$i2007000203293$lle007$op$pE15.00$q-$rl$s- $t0$u6$v2$w6$x0$y.i15193202$z05-11-10 945 $aLE007 174 VER 01.02$g5$i2007000203309$lle007$op$pE15.00$q-$rl$s- $t0$u12$v3$w12$x0$y.i15193172$z05-11-10 996 $aGovernare la vita tra biopotere e biopolitica$9250665 997 $aUNISALENTO 998 $ale007$b05-11-10$cm$da $e-$fita$git $h0$i0 LEADER 03815nam 2201249z- 450 001 9910557354903321 005 20220111 035 $a(CKB)5400000000042340 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76754 035 $a(oapen)doab76754 035 $a(EXLCZ)995400000000042340 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aUrological Cancer 2020 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (334 p.) 311 08$a3-0365-0270-X 311 08$a3-0365-0271-8 330 $aThis Urological Cancer 2020 collection contains a set of multidisciplinary contributions to the extraordinary heterogeneity of tumor mechanisms, diagnostic approaches, and therapies of the renal, urinary tract, and prostate cancers, with the intention of offering to interested readers a representative snapshot of the status of urological research. 606 $aBiology, life sciences$2bicssc 606 $aResearch & information: general$2bicssc 610 $a[68Ga]Ga-PSMA PET/CT 610 $aandrogen receptor 610 $aandrogen response 610 $aangiogenesis 610 $aangiogenic growth factors 610 $aanoikis 610 $aantiangiogenic therapy 610 $aartificial intelligence 610 $abiomarker 610 $abiphasic imaging 610 $abladder cancer 610 $acell proliferation 610 $achelation therapy 610 $aCPT1A 610 $aCXCL9 610 $adeep learning 610 $adelayed imaging 610 $adiagnosis 610 $adifferential diagnosis 610 $aDONSON 610 $aDownstream Neighbor of SON 610 $adual-time point imaging 610 $aen-bloc resection 610 $afatty acids 610 $ahistopathology 610 $aimmunohistochemistry 610 $airon 610 $aKLF5 610 $alesion positivity rate 610 $amachine learning 610 $amacrophages 610 $aMAP1B 610 $ametastatic spread 610 $amicrotubule 610 $aMR-guided 610 $aMRgRT 610 $an/a 610 $aneural network 610 $aoncogenes 610 $aonline adaptive 610 $aoptical mapping 610 $aoxidative stress 610 $apatient-derived xenografts 610 $aPD-L1 610 $aPD1 610 $aprecision medicine 610 $aprevention 610 $aprognosis 610 $aprostate cancer 610 $aprostate carcinoma 610 $aprostate mpMRI 610 $aprostatic neoplasms/epidemiology 610 $aprostatic neoplasms/mortality 610 $aradiotherapy 610 $aRCC 610 $arenal cell cancer 610 $arenal cell carcinoma 610 $arenal tumors 610 $aresearch model 610 $aROS 610 $aSEER Program 610 $aserine 610 $astage T1 NMIBC 610 $astereotactic ablative radiation therapy (SABR) 610 $astereotactic ablative radiotherapy 610 $astroma signature 610 $atherapy 610 $atranscriptome 610 $atransurethral resection 610 $atumor suppressor genes 610 $atumorigenesis 610 $aurothelial carcinoma 610 $avascularity 610 $awhole genome sequencing 610 $a?1-adrenoceptor antagonists 615 7$aBiology, life sciences 615 7$aResearch & information: general 702 $aLo?pez$b Jose? I 906 $aBOOK 912 $a9910557354903321 996 $aUrological Cancer 2020$93038981 997 $aUNINA